REGN $418.62 -3.89 (-0.92%)
Thu, Feb 21, 2019
Regeneron Pharmaceuticals Inc is a Health Care stock that trades on the NASDAQ with a market cap of $46.17 Billion
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis and asthma; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer. http://www.regeneron.com
Regeneron Pharmaceuticals Inc Stock Charts
REGN Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $418.62.
The Year To Date (YTD) return is +12.40%.
52 Week Low
The 52 Week Low stock price is $284.60 set on Wed, May 9, 2018 which is 289 days ago.
The current price per share is 47.09% above the 52 week low.
52 Week High
The 52 Week High stock price is $430.15 set on Fri, Feb 1, 2019 which is 21 days ago.
The current price per share is -2.68% below the 52 week high.
All Time High
The All Time High stock price is $592.40 set on Wed, Aug 5, 2015 which is 1,297 days ago.
The current price per share is -29.33% below the all time high.
REGN Stock Split History
Regeneron Pharmaceuticals Inc has had 0 stock splits.
Below is the EPS, P/E Ratio and Earnings Date.
The Earnings Per Share (EPS) is $7.59.
The Price To Earnings (P/E) Ratio is 24.20.
Regeneron Pharmaceuticals Inc has a relatively low price to earnings ratio compared to the overall S&P 500 average, which is about 25.
Some investors look for very low p/e stocks with the hopes of investing in an undervalued stock. Of course, this is just one factor to consider.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Regeneron Pharmaceuticals Inc was Tue, Nov 6, 2018.
Since this earnings release 108 days ago, the stock price is up by +17.94%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Wed, Feb 6, 2019, which was 16 days ago.
Since this earnings date, the stock price is down by -0.57%.
Regeneron Pharmaceuticals Inc Dividend
Below is important Dividend information.
REGN currently does not pay a dividend.
You may like this list of best dividend stocks of 2019.
Below are some other Biotech & Pharma industry stocks like Regeneron Pharmaceuticals Inc.